Exact Mass: 433.2675534
Exact Mass Matches: 433.2675534
Found 429 metabolites which its exact mass value is equals to given mass value 433.2675534
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Paspalinine
C27H31NO4 (433.22529660000004)
Hericenone B
C27H31NO4 (433.22529660000004)
Hericenone B is found in mushrooms. Hericenone B is isolated from the edible lions mane mushroom (Hericium erinaceum). Isolated from the edible lions mane mushroom (Hericium erinaceum). Hericenone B is found in mushrooms.
N-Arachidonoyl Glutamic acid
N-arachidonoyl glutamic acid, also known as N-arachidonoyl glutamate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Glutamic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Glutamic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Glutamic acid is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Eicosapentaenoyl Methionine
C25H39NO3S (433.26505040000006)
N-eicosapentaenoyl methionine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Methionine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Methionine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Methionine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Mofarotene
Ulipristal
C28H35NO3 (433.26168000000007)
Ilicicolin H
C27H31NO4 (433.22529660000004)
An aromatic ketone in which the ketone carbonyl group is attached to a (1R,2R,4aS,7S,8aR)-4,7-dimethyl-1-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-yl group and a 4-hydroxy-5-(4-hydroxyphenyl)-2-oxo-1,2-dihydropyridin-3-yl group. Isolated from the from the "imperfect" fungus Cylindrocladium iliciola strain MFC-870.
11,12-dihydroxy-13-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-1H,2H,3H,4H,6aH,9H,10H,11H,12H,13H,14H,15H,15bH-cycloundeca[e]isoindole-1,15-dione
(3S,8aS)-3-((7,7-dimethyl-2-(2-methylbut-3-en-2-yl)-1,7-dihydropyrano[2,3-g]indol-3-yl)methyl)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione|notoamide E
C26H31N3O3 (433.23652960000004)
Ser Val Thr Lys
C18H35N5O7 (433.25363600000003)
C25H39NO5_(7E)-11,12-Dihydroxy-3-isobutyl-13-methoxy-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione
C26H31N3O3_Pyrrolo[1,2-a]pyrazine-1,4-dione, 3-[[7-(1,1-dimethyl-2-propen-1-yl)-2,8-dihydro-2,2-dimethylpyrano[3,2-f]indol-6-yl]methyl]hexahydro
C26H31N3O3 (433.23652960000004)
Notoamide E
C26H31N3O3 (433.23652960000004)
A pyranoindole that is notoamide S in which the phenolic hydrosy group at position 6 of the indole moiety has formal addition to the 3-methylbut-2-en-1-yl group at postion 7 of the indole moiety to give the corresponding 7,7-dimethyl-1,7-dihydropyrano[2,3-g]indole derivative. Isolated from a mussel-derived Aspergillus species.
Ala Cys Ile Lys
C18H35N5O5S (433.23587800000007)
Ala Cys Lys Ile
C18H35N5O5S (433.23587800000007)
Ala Cys Lys Leu
C18H35N5O5S (433.23587800000007)
Ala Cys Leu Lys
C18H35N5O5S (433.23587800000007)
Ala Ile Cys Lys
C18H35N5O5S (433.23587800000007)
Ala Ile Lys Cys
C18H35N5O5S (433.23587800000007)
Ala Lys Cys Ile
C18H35N5O5S (433.23587800000007)
Ala Lys Cys Leu
C18H35N5O5S (433.23587800000007)
Ala Lys Ile Cys
C18H35N5O5S (433.23587800000007)
Ala Lys Leu Cys
C18H35N5O5S (433.23587800000007)
Ala Leu Cys Lys
C18H35N5O5S (433.23587800000007)
Ala Leu Lys Cys
C18H35N5O5S (433.23587800000007)
Ala Arg Ser Thr
Ala Arg Thr Ser
Ala Ser Arg Thr
Ala Ser Thr Arg
Ala Thr Arg Ser
Ala Thr Ser Arg
Cys Ala Ile Lys
C18H35N5O5S (433.23587800000007)
Cys Ala Lys Ile
C18H35N5O5S (433.23587800000007)
Cys Ala Lys Leu
C18H35N5O5S (433.23587800000007)
Cys Ala Leu Lys
C18H35N5O5S (433.23587800000007)
Cys Ile Ala Lys
C18H35N5O5S (433.23587800000007)
Cys Ile Lys Ala
C18H35N5O5S (433.23587800000007)
Cys Lys Ala Ile
C18H35N5O5S (433.23587800000007)
Cys Lys Ala Leu
C18H35N5O5S (433.23587800000007)
Cys Lys Ile Ala
C18H35N5O5S (433.23587800000007)
Cys Lys Leu Ala
C18H35N5O5S (433.23587800000007)
Cys Leu Ala Lys
C18H35N5O5S (433.23587800000007)
Cys Leu Lys Ala
C18H35N5O5S (433.23587800000007)
Gly Lys Met Val
C18H35N5O5S (433.23587800000007)
Gly Lys Val Met
C18H35N5O5S (433.23587800000007)
Gly Met Lys Val
C18H35N5O5S (433.23587800000007)
Gly Met Val Lys
C18H35N5O5S (433.23587800000007)
Gly Arg Thr Thr
Gly Thr Arg Thr
Gly Thr Thr Arg
Gly Val Lys Met
C18H35N5O5S (433.23587800000007)
Gly Val Met Lys
C18H35N5O5S (433.23587800000007)
Ile Ala Cys Lys
C18H35N5O5S (433.23587800000007)
Ile Ala Lys Cys
C18H35N5O5S (433.23587800000007)
Ile Cys Ala Lys
C18H35N5O5S (433.23587800000007)
Ile Cys Lys Ala
C18H35N5O5S (433.23587800000007)
Ile Lys Ala Cys
C18H35N5O5S (433.23587800000007)
Ile Lys Cys Ala
C18H35N5O5S (433.23587800000007)
Ile Lys Ser Ser
C18H35N5O7 (433.25363600000003)
Ile Ser Lys Ser
C18H35N5O7 (433.25363600000003)
Ile Ser Ser Lys
C18H35N5O7 (433.25363600000003)
Lys Ala Cys Ile
C18H35N5O5S (433.23587800000007)
Lys Ala Cys Leu
C18H35N5O5S (433.23587800000007)
Lys Ala Ile Cys
C18H35N5O5S (433.23587800000007)
Lys Ala Leu Cys
C18H35N5O5S (433.23587800000007)
Lys Cys Ala Ile
C18H35N5O5S (433.23587800000007)
Lys Cys Ala Leu
C18H35N5O5S (433.23587800000007)
Lys Cys Ile Ala
C18H35N5O5S (433.23587800000007)
Lys Cys Leu Ala
C18H35N5O5S (433.23587800000007)
Lys Gly Met Val
C18H35N5O5S (433.23587800000007)
Lys Gly Val Met
C18H35N5O5S (433.23587800000007)
Lys Ile Ala Cys
C18H35N5O5S (433.23587800000007)
Lys Ile Cys Ala
C18H35N5O5S (433.23587800000007)
Lys Ile Ser Ser
C18H35N5O7 (433.25363600000003)
Lys Leu Ala Cys
C18H35N5O5S (433.23587800000007)
Lys Leu Cys Ala
C18H35N5O5S (433.23587800000007)
Lys Leu Ser Ser
C18H35N5O7 (433.25363600000003)
Lys Met Gly Val
C18H35N5O5S (433.23587800000007)
Lys Met Val Gly
C18H35N5O5S (433.23587800000007)
Lys Ser Ile Ser
C18H35N5O7 (433.25363600000003)
Lys Ser Leu Ser
C18H35N5O7 (433.25363600000003)
Lys Ser Ser Ile
C18H35N5O7 (433.25363600000003)
Lys Ser Ser Leu
C18H35N5O7 (433.25363600000003)
Lys Ser Thr Val
C18H35N5O7 (433.25363600000003)
Lys Ser Val Thr
C18H35N5O7 (433.25363600000003)
Lys Thr Ser Val
C18H35N5O7 (433.25363600000003)
Lys Thr Val Ser
C18H35N5O7 (433.25363600000003)
Lys Val Gly Met
C18H35N5O5S (433.23587800000007)
Lys Val Met Gly
C18H35N5O5S (433.23587800000007)
Lys Val Ser Thr
C18H35N5O7 (433.25363600000003)
Lys Val Thr Ser
C18H35N5O7 (433.25363600000003)
Leu Ala Cys Lys
C18H35N5O5S (433.23587800000007)
Leu Ala Lys Cys
C18H35N5O5S (433.23587800000007)
Leu Cys Ala Lys
C18H35N5O5S (433.23587800000007)
Leu Cys Lys Ala
C18H35N5O5S (433.23587800000007)
Leu Lys Ala Cys
C18H35N5O5S (433.23587800000007)
Leu Lys Cys Ala
C18H35N5O5S (433.23587800000007)
Leu Lys Ser Ser
C18H35N5O7 (433.25363600000003)
Leu Ser Lys Ser
C18H35N5O7 (433.25363600000003)
Leu Ser Ser Lys
C18H35N5O7 (433.25363600000003)
Met Gly Lys Val
C18H35N5O5S (433.23587800000007)
Met Gly Val Lys
C18H35N5O5S (433.23587800000007)
Met Lys Gly Val
C18H35N5O5S (433.23587800000007)
Met Lys Val Gly
C18H35N5O5S (433.23587800000007)
Met Val Gly Lys
C18H35N5O5S (433.23587800000007)
Met Val Lys Gly
C18H35N5O5S (433.23587800000007)
Arg Ala Ser Thr
Arg Ala Thr Ser
Arg Gly Thr Thr
Arg Ser Ala Thr
Arg Ser Thr Ala
Arg Thr Ala Ser
Arg Thr Gly Thr
Arg Thr Ser Ala
Arg Thr Thr Gly
Ser Ala Arg Thr
Ser Ala Thr Arg
Ser Ile Lys Ser
C18H35N5O7 (433.25363600000003)
Ser Ile Ser Lys
C18H35N5O7 (433.25363600000003)
Ser Lys Ile Ser
C18H35N5O7 (433.25363600000003)
Ser Lys Leu Ser
C18H35N5O7 (433.25363600000003)
Ser Lys Ser Ile
C18H35N5O7 (433.25363600000003)
Ser Lys Ser Leu
C18H35N5O7 (433.25363600000003)
Ser Lys Thr Val
C18H35N5O7 (433.25363600000003)
Ser Lys Val Thr
C18H35N5O7 (433.25363600000003)
Ser Leu Lys Ser
C18H35N5O7 (433.25363600000003)
Ser Leu Ser Lys
C18H35N5O7 (433.25363600000003)
Ser Arg Ala Thr
Ser Arg Thr Ala
Ser Ser Ile Lys
C18H35N5O7 (433.25363600000003)
Ser Ser Lys Ile
C18H35N5O7 (433.25363600000003)
Ser Ser Lys Leu
C18H35N5O7 (433.25363600000003)
Ser Ser Leu Lys
C18H35N5O7 (433.25363600000003)
Ser Thr Ala Arg
Ser Thr Lys Val
C18H35N5O7 (433.25363600000003)
Ser Thr Arg Ala
Ser Thr Val Lys
C18H35N5O7 (433.25363600000003)
Ser Val Lys Thr
C18H35N5O7 (433.25363600000003)
Thr Ala Arg Ser
Thr Ala Ser Arg
Thr Gly Arg Thr
Thr Gly Thr Arg
Thr Lys Ser Val
C18H35N5O7 (433.25363600000003)
Thr Lys Val Ser
C18H35N5O7 (433.25363600000003)
Thr Arg Ala Ser
Thr Arg Gly Thr
Thr Arg Ser Ala
Thr Arg Thr Gly
Thr Ser Ala Arg
Thr Ser Lys Val
C18H35N5O7 (433.25363600000003)
Thr Ser Arg Ala
Thr Ser Val Lys
C18H35N5O7 (433.25363600000003)
Thr Thr Gly Arg
Thr Thr Arg Gly
Thr Val Lys Ser
C18H35N5O7 (433.25363600000003)
Thr Val Ser Lys
C18H35N5O7 (433.25363600000003)
Val Gly Lys Met
C18H35N5O5S (433.23587800000007)
Val Gly Met Lys
C18H35N5O5S (433.23587800000007)
Val Lys Gly Met
C18H35N5O5S (433.23587800000007)
Val Lys Met Gly
C18H35N5O5S (433.23587800000007)
Val Lys Ser Thr
C18H35N5O7 (433.25363600000003)
Val Lys Thr Ser
C18H35N5O7 (433.25363600000003)
Val Met Gly Lys
C18H35N5O5S (433.23587800000007)
Val Met Lys Gly
C18H35N5O5S (433.23587800000007)
Val Ser Lys Thr
C18H35N5O7 (433.25363600000003)
Val Ser Thr Lys
C18H35N5O7 (433.25363600000003)
Val Thr Lys Ser
C18H35N5O7 (433.25363600000003)
Val Thr Ser Lys
C18H35N5O7 (433.25363600000003)
Hericenone B
C27H31NO4 (433.22529660000004)
(7E)-11,12-Dihydroxy-3-isobutyl-13-methoxy-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione
Aplidic acid C
C28H35NO3 (433.26168000000007)
NA 28:11;O2
C28H35NO3 (433.26168000000007)
2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-(4-penten-1-yl)-6-heptenoic acid
C27H31NO4 (433.22529660000004)
diethyl 2-acetamido-2-[2-(4-octylphenyl)ethyl]propanedioate
tert-butyl N-[(1S)-2-[(1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexan-2-yl]-1-(3-hydroxy-1-adamantyl)-2-oxoethyl]carbamate
C23H35N3O5 (433.25765800000005)
TERT-BUTYL 4-(2-NITRO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PIPERAZINE-1-CARBOXYLATE
N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide
Ulipristal
C28H35NO3 (433.26168000000007)
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XB - Progesterone receptor modulators G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AD - Emergency contraceptives C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist
Ethanone, 1-[3-ethyl-4-(hydroxymethyl)phenyl]-,O-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methyl]oxime, (1E)-
FMOC-4-CYCLOHEXYL-PIPERIDINE-4-CARBOXYLIC ACID
C27H31NO4 (433.22529660000004)
1H-Indole-1-carboxamide, 6-fluoro-2,3-dihydro-3,3-dimethyl-2-oxo-N-((1-((tetrahydro-4-hydroxy-2H-pyran-4-yl)methyl)-4-piperidinyl)methyl)-
(R)-N-(4-(tert-Butyl)phenyl)-N-(2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl)furan-2-carboxamide
C26H31N3O3 (433.23652960000004)
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(S)-N-(4-(tert-Butyl)phenyl)-N-(2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl)furan-2-carboxamide
C26H31N3O3 (433.23652960000004)
6-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]methyl]-N2-(3-methylphenyl)-1,3,5-triazine-2,4-diamine
{1-[2-(1-Formyl-propyl)-3-methanesulfonylamino-pyrrolidine-1-carbonyl]-2-methyl-propyl}-carbamic acid tert-butyl ester
C19H35N3O6S (433.22464500000007)
Ethyl 3-[7-(diaminomethyl)naphthalen-2-yl]-2-(4-pyrrolidin-3-yloxyphenyl)propanoate
C26H31N3O3 (433.23652960000004)
5,6-Dihydroxy-4-methoxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione
(13S)-7-hydroxy-12,12-dimethyl-8-(3-methylbut-2-enyl)-10,19,21-triazahexacyclo[13.5.2.01,13.03,11.04,9.015,19]docosa-3(11),4(9),5,7-tetraene-20,22-dione
C26H31N3O3 (433.23652960000004)
4-[2-[4-[(Z)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]phenoxy]ethyl]morpholine
2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]pentanedioic acid
N-[2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-1H-imidazole-5-carboxamide
3,4-Dimethoxybenzaldehyde [4-anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]hydrazone
(9E)-5,6-Dihydroxy-4-methoxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione
3-[(2E,4E,8S,10E,12Z)-4,8-dimethyltetradeca-2,4,10,12-tetraenoyl]-4-hydroxy-5-(4-hydroxyphenyl)-1,2-dihydropyridin-2-one
C27H31NO4 (433.22529660000004)
2-[2,4-bis(4-ethoxyphenyl)-6-methyl-1-pyridin-1-iumyl]-N,N-diethylethanamine
2-(dimethylamino)-1-[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
2-(dimethylamino)-1-[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
2-(dimethylamino)-1-[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O5 (433.25765800000005)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide
C23H35N3O5 (433.25765800000005)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C23H35N3O5 (433.25765800000005)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C23H35N3O5 (433.25765800000005)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C23H35N3O5 (433.25765800000005)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C23H35N3O5 (433.25765800000005)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propanoyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O5 (433.25765800000005)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O5 (433.25765800000005)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C23H35N3O5 (433.25765800000005)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
2-(dimethylamino)-1-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
(8R,9S,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
C26H31N3O3 (433.23652960000004)
(8R,9R,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
C26H31N3O3 (433.23652960000004)
(8S,9R,10R)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
C26H31N3O3 (433.23652960000004)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O5 (433.25765800000005)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O5 (433.25765800000005)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O5 (433.25765800000005)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O5 (433.25765800000005)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C23H35N3O5 (433.25765800000005)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(4S,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(5S,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(5S,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C23H35N3O5 (433.25765800000005)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
2-(dimethylamino)-1-[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
2-(dimethylamino)-1-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
2-(dimethylamino)-1-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
(8S,9R,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
C26H31N3O3 (433.23652960000004)
(8R,9S,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
C26H31N3O3 (433.23652960000004)
(8S,9R,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
C26H31N3O3 (433.23652960000004)
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-1-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H31N3O3 (433.23652960000004)
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-1-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H31N3O3 (433.23652960000004)
(1S,9R,10R,11R)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-12-ethyl-10-(hydroxymethyl)-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
C26H31N3O3 (433.23652960000004)
(1R,9S,10S,11S)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-12-ethyl-10-(hydroxymethyl)-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
C26H31N3O3 (433.23652960000004)
3-[2-[2-benzyl-6-[(3R,4R)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol
C26H31N3O3 (433.23652960000004)
2-aminoethyl [3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-hydroxypropyl] hydrogen phosphate
C21H40NO6P (433.2593110000001)
(E)-2-(decanoylamino)-3-hydroxydodec-4-ene-1-sulfonic acid
C22H43NO5S (433.2861788000001)
(E)-3-hydroxy-2-(undecanoylamino)undec-4-ene-1-sulfonic acid
C22H43NO5S (433.2861788000001)
(E)-2-(dodecanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid
C22H43NO5S (433.2861788000001)
(E)-(3R)-(1R,2S,5R)-8-Phenylmenthyl 3-benzylamino-4-hexenoate
N-Formyl-norleucyl-leucyl-phenylalanyl-methylester
C23H35N3O5 (433.25765800000005)
Etrinabdione
C28H35NO3 (433.26168000000007)
Etrinabdione (EHP-101; VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. Etrinabdione inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. Etrinabdione, a semi-synthetic multitarget cannabinoquinoid, has potent anti-inflammatory activity. Etrinabdione attenuates adipogenesis and prevents diet-induced obesity[1][2]. Etrinabdione (EHP-101; VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. Etrinabdione inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. Etrinabdione, a semi-synthetic multitarget cannabinoquinoid, has potent anti-inflammatory activity. Etrinabdione attenuates adipogenesis and prevents diet-induced obesity[1][2].
(1s,2r,3s,5s,6s,8r,9s,10s,13r,17r,18r)-6,8,9-trimethoxy-13-methyl-16-oxo-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate
C24H35NO6 (433.24642500000004)
(1r,2s,3s,4s,5s,6r,8r,9r,10s,13s,16s,17s)-11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
3-[(1r,2s,4as,7s,8as)-4,7-dimethyl-1-[(1e)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-2-carbonyl]-5-(4-hydroxyphenyl)pyridine-2,4-diol
C27H31NO4 (433.22529660000004)
(1s,6r,7s,7ar)-1-benzyl-3-hydroxy-6,7-dimethyl-4-[(4s)-4-[(2s)-3-methyl-5-oxo-2h-furan-2-yl]pent-1-en-1-yl]-1,6,7,7a-tetrahydroisoindol-5-one
C27H31NO4 (433.22529660000004)
13,18-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl benzoate
C27H31NO4 (433.22529660000004)
(2r,3r,4s,5s)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-4-(methylamino)oxane-3,5-diol
C18H35N5O7 (433.25363600000003)
5-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,11,16(24),17,19,21-hexaen-8-one
C27H31NO4 (433.22529660000004)
6-[(2e)-3,7-dimethyl-5-oxoocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one
C27H31NO4 (433.22529660000004)
methyl (4r)-9-[(1s,3ar,4s,7s,7as)-3,3a-dihydroxy-6,7-dimethyl-1-(2-methylpropyl)-1,4,7,7a-tetrahydroisoindol-4-yl]-4-hydroxy-8-methylnona-2,8-dienoate
(3s,8ar)-3-{[2,2-dimethyl-7-(2-methylbut-3-en-2-yl)-8h-chromeno[7,6-b]pyrrol-6-yl]methyl}-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O3 (433.23652960000004)
1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
(1r,2r,4s,5s,16s,19r,23r)-2-hydroxy-4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-22-one
C27H31NO4 (433.22529660000004)
2-[(1-hydroxy-2-{2-[(1-hydroxyethylidene)amino]-n,3-dimethylbutanamido}-3-phenylpropylidene)amino]-4-methylpentanoic acid
C23H35N3O5 (433.25765800000005)
2-(3-{2,4,5,6,8,10-hexamethyltricyclo[6.3.1.0⁴,¹¹]dodeca-2,6,9-trien-12-yl}-1-hydroxyprop-2-en-1-ylidene)-tetrahydropyrrolizine-1,3-dione
C28H35NO3 (433.26168000000007)
(3e,5e,7e,10s,11z,13e,15e,17e,20r)-7,15-dimethyl-20-[(2e,4e)-octa-2,4-dien-1-yl]-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,10-diol
3-benzyl-1,12-dihydroxy-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,11h-cycloundeca[d]isoindol-15-one
C28H35NO3 (433.26168000000007)
(1s,3s,5r,8r,9s,11r,13r,14r,16s,17r,18s,19s)-13,19-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl benzoate
C27H31NO4 (433.22529660000004)
(1s,2s,3s,5r,8r,9s,11r,13r,14s,16s,17r,18r)-2,13-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl benzoate
C27H31NO4 (433.22529660000004)
(1r,4s,5r,16r,19r,23s)-19-hydroxy-4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-22-one
C27H31NO4 (433.22529660000004)
(3r,3as,4r,6ar,10r,12r,15as)-3-benzyl-1,12-dihydroxy-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,11h-cycloundeca[d]isoindol-15-one
C28H35NO3 (433.26168000000007)
3-{[2,2-dimethyl-7-(2-methylbut-3-en-2-yl)-8h-chromeno[7,6-b]pyrrol-6-yl]methyl}-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O3 (433.23652960000004)
(1r,3s,5s,8r,9s,11s,13r,14s,16s,17r,18r)-13,18-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl benzoate
C27H31NO4 (433.22529660000004)
(3s,3ar,4s,6as,10s,12s,15ar)-3-benzyl-1-hydroxy-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,12h,13h,14h-cycloundeca[d]isoindole-11,15-dione
C28H35NO3 (433.26168000000007)
(1s,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
14-ethyl-4-hydroxy-6,19-dimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-one
C24H35NO6 (433.24642500000004)
1,2-dimethyl-7-(prop-1-en-2-yl)-10-oxa-24-azaheptacyclo[13.10.0.0²,¹².0⁵,¹¹.0⁹,¹¹.0¹⁷,²⁵.0¹⁸,²³]pentacosa-17(25),18,20,22-tetraene-8,12-diol
C28H35NO3 (433.26168000000007)
(2s)-2-{[(2r)-1-hydroxy-2-{2-[(1-hydroxyethylidene)amino]-n,3-dimethylbutanamido}-3-phenylpropylidene]amino}-4-methylpentanoic acid
C23H35N3O5 (433.25765800000005)
(1s,6r,7s,7ar)-1-benzyl-3-hydroxy-6,7-dimethyl-4-[(4s)-4-[(2r)-3-methyl-5-oxo-2h-furan-2-yl]pent-1-en-1-yl]-1,6,7,7a-tetrahydroisoindol-5-one
C27H31NO4 (433.22529660000004)
methyl 7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate
(3r,4z,6e)-n-[(5s)-5-ethyl-5-methyl-2-oxofuran-3-yl]-3-hydroxy-8-[(2s,3r)-3-octyloxiran-2-yl]octa-4,6-dienimidic acid
(3s,8as)-3-{[7,7-dimethyl-2-(2-methylbut-3-en-2-yl)-1h-chromeno[5,6-b]pyrrol-3-yl]methyl}-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O3 (433.23652960000004)
6-(3,7-dimethyl-5-oxoocta-2,6-dien-1-yl)-7-hydroxy-5-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one
C27H31NO4 (433.22529660000004)
3-benzyl-1,11-dihydroxy-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,11h,12h-cycloundeca[d]isoindol-15-one
C28H35NO3 (433.26168000000007)
10-hydroxy-7,15-dimethyl-20-(octa-2,4-dien-1-yl)-1-azacycloicosa-3,5,7,11,13,15,17-heptaen-2-one
(1s,2r,5r,7r,8s,9r,11s,12s,15s)-1,2-dimethyl-7-(prop-1-en-2-yl)-10-oxa-24-azaheptacyclo[13.10.0.0²,¹².0⁵,¹¹.0⁹,¹¹.0¹⁷,²⁵.0¹⁸,²³]pentacosa-17(25),18,20,22-tetraene-8,12-diol
C28H35NO3 (433.26168000000007)
5-hydroxy-2-[(4-hydroxyphenyl)methyl]-4-methyl-4-(4,8,10-trimethyldodeca-2,4,6,8,10-pentaenoyl)-2h-pyrrol-3-one
C27H31NO4 (433.22529660000004)
2-hydroxy-4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-22-one
C27H31NO4 (433.22529660000004)
5-benzyl-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.0⁴,⁸.0⁸,¹⁸.0¹¹,¹⁷]nonadeca-6,12-diene-7,9-diol
C28H35NO3 (433.26168000000007)
(1s,3s,4r,5s,8r,9r,11r,14s,16r,17s,18r)-5-benzyl-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.0⁴,⁸.0⁸,¹⁸.0¹¹,¹⁷]nonadeca-6,12-diene-7,9-diol
C28H35NO3 (433.26168000000007)
11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
methyl (1s,4as,4bs,7e,8r,8ar,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate
(2s,3s)-n-[(2s)-5-carbamimidamido-1-oxopentan-2-yl]-2-{[1-hydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-methylpentanimidic acid
C22H35N5O4 (433.26889100000005)
(3r,3as,4r,6ar,10r,11s,12r,15as)-3-benzyl-1,11-dihydroxy-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,11h,12h-cycloundeca[d]isoindol-15-one
C28H35NO3 (433.26168000000007)
(1s,2s,5s,7r,14s)-5-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,11,16(24),17,19,21-hexaen-8-one
C27H31NO4 (433.22529660000004)
3-benzyl-1-hydroxy-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,12h,13h,14h-cycloundeca[d]isoindole-11,15-dione
C28H35NO3 (433.26168000000007)
(4s,6r,10as,13s,13as,14s,16ar)-4,6,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[3,2-d]isoindole-2,5-dione
C24H35NO6 (433.24642500000004)
(3s,3ar,4s,6as,11r,12s,13s,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
(1s,2r,3r,4s,5s,6s,8r,12r,13s,16r,19s,20r)-14-ethyl-4-hydroxy-6,19-dimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-one
C24H35NO6 (433.24642500000004)
(1r,5s,8r,9s,11r,13r,14r,16r,17r,18s,19s)-16,19-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-13-yl benzoate
C27H31NO4 (433.22529660000004)
3-{[7,7-dimethyl-2-(2-methylbut-3-en-2-yl)-1h-chromeno[5,6-b]pyrrol-3-yl]methyl}-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O3 (433.23652960000004)
(3s,3ar,4s,6as,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
3-benzyl-1,6-dihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h-cycloundeca[d]isoindol-15-one
C28H35NO3 (433.26168000000007)
(3s,3ar,4s,6s,6ar,10s,15r,15ar)-3-benzyl-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,15h-cycloundeca[d]isoindole-1,6,15-triol
C28H35NO3 (433.26168000000007)
(1s,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-16-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate
13,19-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl benzoate
C27H31NO4 (433.22529660000004)
11-ethyl-16-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate
methyl (1s,4as,4bs,8r,8ar,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate
3-[(1r,2s,4as,7s,8ar)-4,7-dimethyl-1-[(1e)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-2-carbonyl]-5-(4-hydroxyphenyl)pyridine-2,4-diol
C27H31NO4 (433.22529660000004)
2,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl benzoate
C27H31NO4 (433.22529660000004)
19-hydroxy-4,5,24,24-tetramethyl-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-22-one
C27H31NO4 (433.22529660000004)
2-[(4,6-diamino-3-{[3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl)oxy]-4-(methylamino)oxane-3,5-diol
C18H35N5O7 (433.25363600000003)
(1s,2r,3r,4s,5s,6s,8s,9r,10r,13r,16s,17r,18r)-4-hydroxy-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-18-yl acetate
C24H35NO6 (433.24642500000004)
(2r,3r,4s,5r)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-4-(methylamino)oxane-3,5-diol
C18H35N5O7 (433.25363600000003)
(4z,6e)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid
n-{5-methoxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl}-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35NO6 (433.24642500000004)
(2s)-5-methoxy-2-methyl-2-(4-methyl-2-oxopent-3-en-1-yl)-8-(2-phenylethyl)-3h,4h,9h-pyrano[2,3-e]isoindol-7-one
C27H31NO4 (433.22529660000004)
3-benzyl-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,15h-cycloundeca[d]isoindole-1,6,15-triol
C28H35NO3 (433.26168000000007)
methyl (1s,4ar,4bs,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9,10-dioxo-octahydro-2h-phenanthrene-1-carboxylate
C24H35NO6 (433.24642500000004)
(2s,4r)-5-hydroxy-2-[(4-hydroxyphenyl)methyl]-4-methyl-4-[(2e,4e,6e,8e,10e)-4,8,10-trimethyldodeca-2,4,6,8,10-pentaenoyl]-2h-pyrrol-3-one
C27H31NO4 (433.22529660000004)
methyl (1s,4ar,4br,7e,8s,10ar)-9-hydroxy-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-10-oxo-2,3,4,4b,5,6,8,10a-octahydrophenanthrene-1-carboxylate
C24H35NO6 (433.24642500000004)
(2e,4e,6r)-n-[(1's,3'r,4s,5r,5's,7'r)-5-methoxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35NO6 (433.24642500000004)
4,6,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindole-2,5-dione
C24H35NO6 (433.24642500000004)
(3r,3as,4r,6r,6as,10r,12s,15ar)-3-benzyl-1,6-dihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h-cycloundeca[d]isoindol-15-one
C28H35NO3 (433.26168000000007)
2,13-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl benzoate
C27H31NO4 (433.22529660000004)
methyl (1s,4ar,4bs,7e,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9,10-dioxo-octahydro-2h-phenanthrene-1-carboxylate
C24H35NO6 (433.24642500000004)
(2z,7as)-2-[(2e)-3-[(1r,4s,5s,8r,11r,12r)-2,4,5,6,8,10-hexamethyltricyclo[6.3.1.0⁴,¹¹]dodeca-2,6,9-trien-12-yl]-1-hydroxyprop-2-en-1-ylidene]-tetrahydropyrrolizine-1,3-dione
C28H35NO3 (433.26168000000007)
5-methoxy-2-methyl-2-(4-methyl-2-oxopent-3-en-1-yl)-8-(2-phenylethyl)-3h,4h,9h-pyrano[2,3-e]isoindol-7-one
C27H31NO4 (433.22529660000004)
(3s,3ar,4s,6as,11s,12s,13s,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
methyl 9-hydroxy-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-10-oxo-2,3,4,4b,5,6,8,10a-octahydrophenanthrene-1-carboxylate
C24H35NO6 (433.24642500000004)